{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:16:12Z","timestamp":1777612572359,"version":"3.51.4"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Keishi-bukuryo-gan is a traditional herbal medicine, which is used clinically as a vascular system disorder-eliminating drug. In this study, its effect on the progression of diabetic nephropathy in experimental rats was investigated. The diabetic nephropathy model used in this study shows functional and morphological changes of the kidney resembling those seen in patients with diabetic nephropathy. Increased proteinuria and serum urea nitrogen and creatinine levels and decreased creatinine clearance, which are important parameters of renal function, were observed in rats with diabetic nephropathy. Pathological examination of the kidney revealed diffuse, nodular and exudative lesions and arteriolar hyalinosis. The deterioration of renal function was ameliorated in rats treated with Keishi-bukuryo-gan for 15 weeks and these results agreed with the renal histological findings. In addition, metabolic abnormalities mediated by persistent hyperglycaemia (the glycation reaction, excessive polyol pathway activity, oxidative stress and lipid metabolic abnormalities) were also observed. However, Keishi-bukuryo-gan reduced accumulation of advanced glycation end products, determined by measuring fluorescence, and serum lipid peroxidation, triglyceride and total cholesterol levels dose-dependently. Thus, this study indicates the potential therapeutic usefulness of Keishi-bukuryogan for retarding the progression of renal damage and suggests that its beneficial effects were due to its ability to improve metabolic abnormalities associated with diabetes.<\/jats:p>","DOI":"10.1211\/002235702450","type":"journal-article","created":{"date-parts":[[2003,3,4]],"date-time":"2003-03-04T05:15:57Z","timestamp":1046754957000},"page":"219-227","source":"Crossref","is-referenced-by-count":40,"title":["Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy"],"prefix":"10.1093","volume":"55","author":[{"given":"Takako","family":"Nakagawa","sequence":"first","affiliation":[{"name":"Institute of Natural Medicine, Toyama Medical and Pharmaceutical University , 2630 Sugitani, Toyama 930\u20130194,","place":["Japan"]},{"name":"Department of Japanese Oriental Medicine, Toyama Medical and Pharmaceutical University , 2630 Sugitani, Toyama 930\u20130194,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Yokozawa","sequence":"additional","affiliation":[{"name":"Institute of Natural Medicine, Toyama Medical and Pharmaceutical University , 2630 Sugitani, Toyama 930\u20130194,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutoshi","family":"Terasawa","sequence":"additional","affiliation":[{"name":"Department of Japanese Oriental Medicine, Toyama Medical and Pharmaceutical University , 2630 Sugitani, Toyama 930\u20130194,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Aso lizuka Hospital , 3\u201383 Yoshiomachi, lizuka 820\u20138505,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2003,2,1]]},"reference":[{"key":"2024103109391020200_cit1","doi-asserted-by":"crossref","first-page":"16969","DOI":"10.1016\/S0021-9258(18)45479-8","article-title":"Glycation and inactivation of human Cu-Zn-superoxide dismutase. Identification of the in vitro glycated sites","volume":"262","author":"Arai","year":"1987","journal-title":"J. Biol. Chem."},{"key":"2024103109391020200_cit2","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJM198805193182007","article-title":"Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications","volume":"318","author":"Brownlee","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"2024103109391020200_cit3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(08)60961-8","article-title":"Advanced glycosylation: chemistry, biology, and implications for diabetes and aging","volume":"23","author":"Bucala","year":"1992","journal-title":"Adv. Pharmacol."},{"key":"2024103109391020200_cit4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00405080","article-title":"The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus","volume":"34","author":"Chang","year":"1991","journal-title":"Diabetologia"},{"key":"2024103109391020200_cit5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2337\/diacare.19.3.257","article-title":"Oxidative stress and diabetic vascular complications","volume":"19","author":"Giugliano","year":"1996","journal-title":"Diabetes Care"},{"key":"2024103109391020200_cit6","first-page":"198","article-title":"A report of three cases of diabetic nephropathy satisfactorily treated with traditional herbal medicine","volume":"17","author":"Goto","year":"2000","journal-title":"J. Trad. Med."},{"key":"2024103109391020200_cit7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0168-8227(99)00044-3","article-title":"Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C","volume":"45","author":"Ha","year":"1999","journal-title":"Diabetes Res. Clin. Prac."},{"key":"2024103109391020200_cit8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/bj2910529","article-title":"Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Some fundamental differences in proposed mechanisms of glucose oxidation and oxidant production","volume":"291","author":"Hunt","year":"1993","journal-title":"Biochem. J."},{"key":"2024103109391020200_cit9","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2337\/diab.28.11.1011","article-title":"Nonenzymatic glucosylation of serum proteins in diabetes mellitus","volume":"28","author":"McFarland","year":"1979","journal-title":"Diabetes"},{"key":"2024103109391020200_cit10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0003-2697(78)90342-1","article-title":"Determination of malonaldehyde precursor in tissues by thiobarbituric acid test","volume":"86","author":"Mihara","year":"1978","journal-title":"Anal. Biochem."},{"key":"2024103109391020200_cit11","first-page":"S35","article-title":"Lipids and progressive kidney disease","volume":"31","author":"Moorhead","year":"1991","journal-title":"Kidney Int."},{"key":"2024103109391020200_cit12","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0140-6736(90)93090-C","article-title":"Relation between serum cholesterol and diabetic nephropathy","volume":"335","author":"Mulec","year":"1990","journal-title":"Lancet"},{"key":"2024103109391020200_cit13","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0006-291X(05)80875-7","article-title":"Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes","volume":"173","author":"Mullarkey","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2024103109391020200_cit14","first-page":"187","article-title":"Lipid peroxides in atherosclerotic diseases","volume":"15","author":"Naito","year":"1978","journal-title":"Jpn. J. Geriatrics"},{"key":"2024103109391020200_cit15","first-page":"161","article-title":"A study of Kampo medicines in a diabetic nephropathy model","volume":"18","author":"Nakagawa","year":"2001","journal-title":"J. Trad. Med."},{"key":"2024103109391020200_cit16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2337\/diab.42.2.345","article-title":"Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat","volume":"42","author":"Nakayama","year":"1993","journal-title":"Diabetes"},{"key":"2024103109391020200_cit17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2337\/diab.40.5.527","article-title":"Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 mo of aldose reductase inhibition","volume":"40","author":"Pedersen","year":"1991","journal-title":"Diabetes"},{"key":"2024103109391020200_cit18","first-page":"115","article-title":"Total protein","volume-title":"Rinsho Kagaku Bunseki II","author":"Sakagishi","year":"1968"},{"key":"2024103109391020200_cit19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0006-2944(79)90061-9","article-title":"Lipid peroxide level in plasma of diabetic patients","volume":"21","author":"Sato","year":"1979","journal-title":"Biochem. Med."},{"key":"2024103109391020200_cit20","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0304-4165(98)00111-1","article-title":"Effects of thyroid hormone on the sorbitol pathway in streptozotocin-induced diabetic rats","volume":"1425","author":"Shinohara","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"2024103109391020200_cit21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1172\/JCI113641","article-title":"Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats","volume":"82","author":"Suarez","year":"1988","journal-title":"J. Clin. Invest."},{"key":"2024103109391020200_cit22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0024-3205(01)01183-3","article-title":"Hyperglycemia in diabetic rats reduces the glutathione content in the aortic tissue","volume":"69","author":"Tachi","year":"2001","journal-title":"Life Sci."},{"key":"2024103109391020200_cit23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/ki.1992.121","article-title":"Diabetes-induced glomerular dysfunction: links to a more reduced cytosolic ratio of NADH\/ NAD+","volume":"41","author":"Tilton","year":"1992","journal-title":"Kidney Int."},{"key":"2024103109391020200_cit24","first-page":"138","article-title":"Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging","volume":"70","author":"Vlassara","year":"1994","journal-title":"Lab. Invest."},{"key":"2024103109391020200_cit25","doi-asserted-by":"crossref","first-page":"11704","DOI":"10.1073\/pnas.91.24.11704","article-title":"Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats","volume":"91","author":"Vlassara","year":"1994","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2024103109391020200_cit26","first-page":"21","article-title":"Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications","volume":"50","author":"Yabe-Nishimura","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"2024103109391020200_cit27","first-page":"107","article-title":"Effects of Oriental medicines on the production of advanced glycation endproducts","volume":"18","author":"Yokozawa","year":"2001","journal-title":"J. Trad. Med."},{"key":"2024103109391020200_cit28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1078\/0940-2993-00203","article-title":"Animal model of diabetic nephropathy","volume":"53","author":"Yokozawa","year":"2001","journal-title":"Exp. Toxic. Pathol."}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1211%2F002235702450","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/55\/2\/219\/60259501\/002235702450.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/55\/2\/219\/60259501\/002235702450.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T10:10:05Z","timestamp":1730369405000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/55\/2\/219\/6148188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,1]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2003,2,1]]},"published-print":{"date-parts":[[2003,2,1]]}},"URL":"https:\/\/doi.org\/10.1211\/002235702450","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2003,2]]},"published":{"date-parts":[[2003,2,1]]}}}